Kowa Company, Ltd. et al v. Aurobindo Pharma Limited et al
| Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd. |
| Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd. |
| 1:2014cv02497 |
| April 9, 2014 |
| US District Court for the Southern District of New York |
| Foley Square Office |
| XX Out of U.S. |
| Paul A. Crotty |
| Patent |
| 35 U.S.C. ยง 271 |
| None |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
93
OPINION & ORDER. The Court holds that claim construction is not necessary. The parties are directed to proceed with expert discovery according to the timeline as set forth in the Scheduling Order. See Dkt. 93. (As further set forth in this Order) (Signed by Judge Paul A. Crotty on 11/4/2015) (lmb)
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
